Summary: | Objective: The purpose of this study was to determine the role of multidetector computed tomography (MDCT) in evaluation and prediction of pancreatic tumors resectability.
Patients and methods: The study included 20 patients who had pancreatic masses, 16 males and 4 females, and their age range was 30–70 years with a mean age of 58.0 years. All the patients underwent non-contrast and contrast enhanced Multi-slice CT using a 16-slice machine. The gold standard for diagnosis was histopathology and operative data.
Results: Adenocarcinoma as reported by pathological studies was found in 8 patients, cyst adenocarcinoma in one patient, infiltrative adenocarcinoma in 2 patients, intraductal papillary mucinous tumor in 2 patients, mucinous cyst adenocarcinoma in one patient, pancreatic pseudo cyst in 2 patients and mucinous cystadenoma in 4 patients. According to MDCT criteria 6 patients were considered suitable for tumor resection and 14 patients were considered inoperable with unresectable tumor, one out of the 6 operable patients was unresectable during operation due to the invasion of the superior mesenteric vein with infiltration of the mesenteric root.
Conclusion: Contrast-enhanced multiphase pancreatic imaging by multislice computerized tomography (MSCT) with its postprocessing techniques represents the image of choice for diagnosis and predicting pancreatic masses and resectability.
|